Search Results - Simon Rule

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin by Michelle Furtado, Simon Rule

    Published in Clinical Medicine Insights: Oncology (2012-01-01)
    Get full text
    Article


  2. 2

    Indolent mantle cell lymphoma by Michelle Furtado, Simon Rule

    Published in Haematologica (2011-08-01)
    Get full text
    Article


  3. 3

    Reducing Bureaucracy in Clinical Research: A Call for Action by John Gribben, Elizabeth Macintyre, Pieter Sonneveld, Jeanette Doorduijn, Christian Gisselbrecht, Ulrich Jäger, Steven Le Gouill, Simon Rule, Martin Dreyling

    Published in HemaSphere (2020-04-01)
    Get full text
    Article


  4. 4

    Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma by Andrew Grigg, Martin J.S. Dyer, Marcos González Díaz, Martin Dreyling, Simon Rule, Guiyuan Lei, Andrea Knapp, Elisabeth Wassner-Fritsch, Paula Marlton

    Published in Haematologica (2017-04-01)
    Get full text
    Article


  5. 5

    Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis by Simon Rule, Martin Dreyling, Andre Goy, Georg Hess, Rebecca Auer, Brad Kahl, José-Ángel Hernández-Rivas, Keqin Qi, Sanjay Deshpande, Lori Parisi, Michael Wang

    Published in Haematologica (2019-05-01)
    Get full text
    Article


  6. 6

    Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004) by Michael Wang, Stephen J. Schuster, Tycel Phillips, Izidore S. Lossos, Andre Goy, Simon Rule, Mehdi Hamadani, Nilanjan Ghosh, Craig B. Reeder, Evelyn Barnett, Marie-Laure Casadebaig Bravo, Peter Martin

    Published in Journal of Hematology & Oncology (2017-11-01)
    Get full text
    Article


  7. 7

    Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study by Paolo Strati, Sven de Vos, Jia Ruan, Kami J. Maddocks, Christopher R. Flowers, Simon Rule, Priti Patel, Yan Xu, Helen Wei, Melanie M. Frigault, Roser Calvo, Martin J.S. Dyer

    Published in Haematologica (2021-07-01)
    Get full text
    Article


  8. 8

    P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION. by Steven Le Gouill, Franck Morschhauser, David Chiron, Kamal Bouabdallah, Guillaume Cartron, Rene Olivier Casasnovas, Caroline Milin, Charles Herbaux, Emmanuelle Tchernonog, Cedric Rossi, Simon Rule, Thomas Gastinne, Mary Callanan, Benoit Tessoulin

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  9. 9

    Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III... by Simon Rule, Wolney Gois Barreto, Javier Briones, Angelo M. Carella, Olivier Casasnovas, Chris Pocock, Clemens-Martin Wendtner, Francesco Zaja, Susan Robson, Lachlan MacGregor, Roger R. Tschopp, Sonja Nick, Martin Dreyling

    Published in Haematologica (2021-06-01)
    Get full text
    Article


  10. 10

    ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for... by Andrew Davies, Sharon Barrans, Cathy Burton, Katy Mercer, Joshua Caddy, Fay Chinnery, Laura Day, Diana Fernando, Kirit Ardeshna, Graham Collins, John Radford, Simon Rule, Andrew McMillan, Peter Johnson, Gareth Griffiths

    Published in F1000Research (2020-08-01)
    Get full text
    Article


  11. 11

    Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial by Elizabeth H. Phillips, Catherine Burton, Amy A. Kirkwood, Sharon Barrans, Anthony Lawrie, Simon Rule, Russell Patmore, Ruth Pettengell, Kirit M. Ardeshna, Silvia Montoto, Shankara Paneesha, Laura Clifton‐Hadley, David C. Linch, Andrew K. McMillan

    Published in eJHaem (2020-07-01)
    Get full text
    Article


  12. 12

    The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lym... by Simon Rule, Paul Smith, Peter W.M. Johnson, Simon Bolam, George Follows, Joanne Gambell, Peter Hillmen, Andrew Jack, Stephen Johnson, Amy A Kirkwood, Anton Kruger, Christopher Pocock, John F. Seymour, Milena Toncheva, Jan Walewski, David Linch

    Published in Haematologica (2016-02-01)
    Get full text
    Article


  13. 13

    Is Good Clinical Practice Becoming Poor Clinical Care? by Steven Le Gouill, Martin Dreyling, Maria Dolores Caballero, Marc Andre, Jeannette Doorduijn, Wojciech Jurczak, Mats Jerkeman, Paolo Ghia, Pier-Luigi Zinzani, Maria Gomez Da Silva, Meletios Dimopoulos, Marek Trneny, Richard Delarue, Jan Walewski, Christian Gisselbrecht, Armando López-Guillermo, Simon Rule

    Published in HemaSphere (2017-12-01)
    Get full text
    Article


  14. 14

    Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial by Carla Casulo, Armando Santoro, Guillaume Cartron, Kiyoshi Ando, Javier Munoz, Steven Le Gouill, Koji Izutsu, Simon Rule, Pieternella Lugtenburg, Jia Ruan, Luca Arcaini, Marie‐Laure Casadebaig, Brian Fox, Nurgul Kilavuz, Nils Rettby, Justine Dell'Aringa, Lilia Taningco, Richard Delarue, Myron Czuczman, Thomas Witzig

    Published in Cancer Reports (2023-01-01)
    Get full text
    Article


  15. 15

    Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prog... by Steven Le Gouill, Monika Długosz-Danecka, Simon Rule, Pier Luigi Zinzani, Andre Goy, Stephen D. Smith, Jeanette K. Doorduijn, Carlos Panizo, Bijal D. Shah, Andrew J. Davies, Richard Eek, Eric Jacobsen, Arnon P. Kater, Tadeusz Robak, Preetesh Jain, Roser Calvo, Lin Tao, Michael Wang

    Published in Haematologica (2023-07-01)
    Get full text
    Article


  16. 16

    Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials by Jennifer R. Brown, Javid Moslehi, Susan O’Brien, Paolo Ghia, Peter Hillmen, Florence Cymbalista, Tait D. Shanafelt, Graeme Fraser, Simon Rule, Thomas J. Kipps, Steven Coutre, Marie-Sarah Dilhuydy, Paula Cramer, Alessandra Tedeschi, Ulrich Jaeger, Martin Dreyling, John C. Byrd, Angela Howes, Michael Todd, Jessica Vermeulen, Danelle F. James, Fong Clow, Lori Styles, Rudy Valentino, Mark Wildgust, Michelle Mahler, Jan A. Burger

    Published in Haematologica (2017-10-01)
    Get full text
    Article


Search Tools: